About
0.46CAD+0.02 +3.41%
Closed • Updated at 16:42 GMT+00:00Market Cap$22.69M
Volume53.9K
Beta1.94
RSI34.08
Medicenna Therapeutics Corp. — investor relations, events, news, and company updates on 6ix.
Latest News
May 22 2026
Medicenna Announces the Filing of its Prospectus Supplement and Investment Term Sheet
May 19 2026
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
May 13 2026
Medicenna Announces the Launch of a Marketed Public Offering of Securities
May 12 2026
Medicenna and Fondazione Melanoma Onlus Announce First Patient Dosed in the NEO-CYT Study of MDNA11 in Neoadjuvant Melanoma
Apr 30 2026
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
Community Chat
Ask AI
Try asking
Google Übersetzer